MEDICA and COMPAMED 2020 to be launched as 'virtual.MEDICA' and 'virtual.COMPAMED' with three focal areas
MEDICA 2020 and COMPAMED 2020, the world-leading information and communication platforms for the medical technology industry and supplier industry for the medical technology industry, will take place entirely online from 16 to 19 November 2020. Within the framework of 'virtual.MEDICA' and 'virtual.COMPAMED', decision-makers from all sectors of the healthcare industry can then expect a comprehensive range of products and services at https://virtual.medica.de and https://virtual.compamed.de consisting of three focal areas: The Conference Area (conference and forum program), the Exhibition Space (for exhibitors and product innovations) and theNetworking Plaza (networking/ matchmaking).
Scientists have created synthetic soft surfaces with tongue-like textures for the first time using 3D printing, opening new possibilities for testing oral processing properties of food, nutritional technologies, pharmaceutics and dry mouth therapies.
Demonstrated the mechanism behind the secondary generation of cavitation clouds that mechanically fractionates surrounding tissue in focused ultrasound treatment. Laid the groundwork for precise removal of the target tissue.
The findings by imaging specialists at NYU Grossman School of Medicine center on small bright spots on scans called white matter hyperintensities. Increased numbers and size of the intense-white spots seen on the mostly gray images of the brain have long been linked to memory loss and emotional problems, especially as people age.
A test to diagnose two very serious diseases such as ALS and FTD when the pathologies have not yet appeared, thereby providing doctors and patients with essential information tools to tackle them early and develop new treatments. A team of researchers at SISSA in association with different clinical and Italian research institutes have made a first promising step in this direction.
A research team from the University of Jaén has patented a novel disinfectant formula that not only eliminates pathogenic bacteria, but also stops their ability to evolve genetically developing resistance against antimicrobial agents. The composition uses sustainable agents that degrade easily in the environment without harming it.
Stress is present everywhere, even bacteria and plant cells have to cope with it. They express various specific stress proteins, but how exactly this line of defense works is often not clear. A group of scientists headed by Professor Dirk Schneider of Johannes Gutenberg University Mainz (JGU) has now discovered a protective mechanism in cyanobacteria as well as in chloroplasts of plant cells.
You are invited to join the search for COVID-19 treatments--no lab coat or Ph.D. necessary: Anyone with a smartphone can download the app ViDok, which lets users pick from a library of molecules that might bind to key proteins on the SARS-CoV-2 virus, which causes COVID-19, and then can tweak the molecules to try to find a better fit.
Scientists have engineered tissue grafts that, in pigs, regenerated both bone and cartilage in the temporomandibular joint (TMJ), a part of the jaw that can cause debilitating pain and disability when damaged.
Researchers of the Technical University of Munich (TUM) have cultured so-called intestinal organoids from human intestinal tissue, which is a common byproduct when performing bowel surgery. These small “miniature intestines” can be used for molecular biological examinations and allow for a direct application of research results to humans, thereby making animal experiments redundant.
A new study jointly led by Professor Tom Wilkinson and Dr Tristan Clark of the University of Southampton, has shown a blood test for five cytokines could help predict those at risk of life-threating overstimulation of immune defenses by COVID-19, and potentially tailor their treatment to tackle this.
The Technical University of Munich (TUM) is starting five new research projects that focus on the coronavirus and the search for new active ingredients. For example, the use of algorithms could ensure a more precise classification of the illness in the future.
In Judith Su's Little Sensor Lab, researchers are working to sense tiny amounts - down to a single molecule - of everything from doping agents to biomarkers for cancer, Alzheimer's disease, Lyme disease and, yes, even COVID-19.
A bioceramic implant has proved to stimulate regeneration of natural skull bone, so that even large cranial defects can be repaired in a way that has not been possible before. The research, led from the University of Gothenburg, is presented in the scientific journal PNAS.
Researchers with the U.S. Army Futures Command are part of a team that tested alternative ways to measure COVID-19 antibody levels, resulting in a process that is faster, easier and less expensive to use on a large scale. Their method holds promise for accurately identifying potential donors who have the best chance of helping infected patients through convalescent plasma therapy.
When the Zucker Institute for Applied Neurosciences (ZIAN) at the Medical University of South Carolina needed to bring to life a neurosurgeon's idea for better instrumentation for sacroiliac surgery, there was one obvious partner to turn to: the MUSC College of Dental Medicine.
Rapid detection of the SARS-CoV-2 virus, in about 30 seconds following the test, has had successful preliminary results in Mano Misra's lab at the University of Nevada, Reno. The test uses a nanotube-based electrochemical biosensor, a similar technology that Misra has used in the past for detecting tuberculosis and colorectal cancer as well as detection of biomarkers for food safety.
Around 15 percent of Parkinson's disease cases are related to a known genetic background, out of which mutations in the Parkin and PINK1 genes are among the most frequent ones. Thus, revealing cellular mechanisms which are altered by these mutations is crucial for the development of new therapeutic approaches.
Extracellular vesicles (EVs) - nanometer sized messengers that travel between cells to deliver cues and cargo - are promising tools for the next generation of therapies for everything from autoimmune and neurodegenerative diseases to cancer and tissue injury.
Genetic mutations that promote the growth of the most common type of adult brain tumors can be accurately detected and monitored in blood samples using an enhanced form of liquid biopsy developed by researchers at Massachusetts General Hospital (MGH).
The closer people are physically to one another, the higher the chance for exchange, of things like ideas, information, and even infection. Now researchers at MIT and Boston Children's Hospital have found that, even in the microscopic environment within a single cell, physical crowding increases the chance for interactions, in a way that can significantly alter a cell's health and development.
Scientists have made a breakthrough in their work to develop semi-autonomous colonoscopy, using a robot to guide a medical device into the body. The milestone brings closer the prospect of an intelligent robotic system being able to guide instruments to precise locations in the body to take biopsies or allow internal tissues to be examined.
Whether in fitness, medicine or in the entertainment industry, IT devices worn on the body, such as smart watches, are becoming increasingly popular. Such wearables benefit from the input device fitting as naturally as possible to the body – for example as electro-sensitive fabrics, so-called e-textiles.
The authors, two surgeon-researchers from Murayama Medical Center in Tokyo, tested a device that, when attached to everyday eyeglasses, can display fluoroscopic images used for surgical guidance directly to the surgeon. Without such a device, the surgeon must receive this guidance by repeatedly looking across the operating room to a video monitor.
The medical technology industry is facing major challenges due to digitalization, new manufacturing technologies and changes in the regulatory framework. In order to strengthen the innovative power of the SME-driven German medical technology industry, the BMBF joint project "EUREKA-AMeLie aims to create new opportunities for a structure for networked product development.
It was only thanks to the Rossmax blood pressure monitor PARR X5 that 55-year-old Robert Schär noticed at the right moment that he had atrial fibrillation in order to avert worse. “I have been treated...
During this Coronavirus crisis, all the attention of clinicians around the world lays on the direct diagnosis of the COVID-19 disease, whether by PCR, Rapid Tests or classical serology. However, cell...
With Lumix Q Platform, Nd:YAG Q-Switched laser Platform, the 320um optical fiber is inserted into the subcutaneous tissue of the area to be treated, avoiding any kind of tissue trauma. All the laser...
Nordion is one of the pioneers in using Cobalt-60 for gamma sterilization. The company has been building irradiators and shipping Cobalt sources around the world for more than 50 years and continues...
Sri Trang Group proudly received multiple FSC™ (Forest Stewardship Council ™) certifications for international standards including: FSC-FM (Forest Management Certification), FSC-COC (Chain-of-Custody...
AirSep Corporation, a CAIRE Inc. company, develops innovative, economical, non-cryogenic oxygen supply solutions as a safer alternative to cylinder or liquid supplies- providing a reliable source of...
Springfield, MA – Super Brush LLC. A manufacturing leader in foam swabs and applicators announced today that the company has earned ISO 13485:2016 certification for its quality management system. ISO...
Unlike the products marketed to date, the test developed by SYnabs, Coris BioConcept, Unisensor, and Bio- X Diagnostics, is the only rapid solution (developed in different formats) that can detect an...